Hunan University of Medicine General Hospital
Hunan University of Medicine General Hospital
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subarachnoid Hemorrhage, Aneurysmal, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracranial vasospasm, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Not yet recruiting | Not applicable | 2026-09-23 | NCT07643922 | |
| ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC | Neoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Not stated | 2026-08-31 | NCT05198154 | |
| A Prospective Multicenter Observational Real-world Study of Retained Products of Conception | RPOC; Retained Products of Conception | Recruiting | Not stated | 2026-02-19 | NCT07421895 | |
| Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN) | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 3 | 2022-03-03 | NCT05044117 |